India surged to ₹469.50 today (+1.91%) with a strong bullish candle breaking above both key moving averages (white and green lines). This breakout signals a potential trend reversal after a period of consolidation near ₹455–₹460. The momentum looks positive, and if price sustains above ₹470, next resistance could be ₹490, followed by ₹512 (recent high).
Short-term support is ₹461 and ₹460; as long as price stays above these levels, the uptrend may continue. Watch for volume confirmation and follow-up movement in next sessions for a decisive trend. If price falls below ₹460 again, it may go back into the previous sideways zone.
Fundamental Catalyst - The US has exempted the Indian pharma industry from immediate tariff raise, recognizing the importance of generic medications for affordable healthcare.
This analysis is published by a SEBI RA FIRM UNITE TECHNOLOGIES FINANCIAL SERVICE INH000020350 and is intended solely for educational and informational purposes. It should not be considered as investment advice or a recommendation to buy, sell, or hold any securities. Please consult your financial advisor before making any trading decisions. Investing in equities is subject to market risks; past performance is not indicative of future results.